Bio
Eric Meier brings over 25 years of experience in the development of innovative software, medical devices, and drug delivery solutions. Prior to Owl Insights, Eric served as CEO of Cervel Neurotech, a non-invasive deep brain stimulation offering for the treatment of psychiatric and neurological disorders, until its sale to Rio Grande Neuroscience. Previously, he was Founder and CEO of Calypso Medical, a platform for the delivery of targeted external beam radiation treatment, which was acquired by Varian Medical Systems. Eric also led a variety of corporate development activities at Johnson & Johnson. Eric received his MBA from Stanford University.